title: Minimum alveolar concentration of sevoflurane in rabbits with liver fibrosis.
abstract: BACKGROUND
  Sevoflurane is widely used in patients undergoing surgical procedures, which could affect both the liver function and hepatic blood flow. However, the effects of liver fibrosis on minimum alveolar concentration (MAC) of sevoflurane are still unclear. Therefore, we designed this study to determine the MAC of sevoflurane in rabbits with liver fibrosis.
  
  
  METHODS
  Thirty male New Zealand white rabbits weighing approximately 2.5 kg were divided randomly into 2 groups: fibrosis (n = 20) and normal control group (n = 10). The rabbits in the fibrosis group were treated with 50% carbon tetrachloride for 12 weeks to induce liver fibrosis. The serum concentration of total protein, albumin, globulin, total bile acids, alanine aminotransferase, aspartame aminotransferase, alkaline phosphatase, γ-glutamyl transpeptidase, total bilirubin, direct bilirubin, and indirect bilirubin were measured before anesthesia. The anesthesia for animals that survived in both groups was induced and maintained with sevoflurane. A standard tail-clamp technique was used to determine the MAC of sevoflurane in spontaneously breathing rabbits. After anesthesia, animals were killed for liver pathologic examination.
  
  
  RESULTS
  Twelve weeks after 50% carbon tetrachloride administration, 14 of 20 rabbits survived in the fibrosis group, and 9 of 10 survived in the control group. All surviving animals in the fibrosis group had developed moderate to severe liver fibrosis. Three rabbits that survived after the fibrosis challenge were excluded for other diseases or no response to pain stimulation. The levels of globulin, aspartame aminotransferase, and γ-glutamyl transpeptidase significantly increased in fibrosis animals compared with controls. However, the albumin and alkaline phosphatase levels were significantly lower in the fibrosis group than in the control group. Mean arterial blood pressure, heart rate, end-tidal CO(2), and temperature were stable in both groups during sevoflurane anesthesia. The MAC of sevoflurane was significantly less in the fibrosis group than in the control group (3.52% vs 4.10%, P = 0.018).
  
  
  CONCLUSIONS
  The MAC of sevoflurane decreased significantly in rabbits with liver fibrosis.
authors.affiliation: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Yin
authors.forename: Ming
authors.initials: M
authors.lastname: Yan
authors.forename: Tao
authors.initials: T
authors.lastname: Zhu
mesh_terms: D018685:Anesthetics, Inhalation / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D008103:Liver Cirrhosis / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008738:Methyl Ethers / Q000378:metabolism* / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000378:metabolism*; D011817:Rabbits; D011897:Random Allocation; D000077149:Sevoflurane
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane